Episode 727
TWiV 727: COVID-19 clinical update #52 with Dr. Daniel Griffin
March 6, 202135m 20s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In COVID-19 clinical update #52, Daniel Griffin reviews differences in attack rates between children and adults, J&J vaccine phase III data, G6PD deficiency and vaccines, NIH halts convalescent plasma trial, dexamethasone in hospitalized patients, data on tocilizumab, and long COVID in children.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- SARS-CoV-2 attack rates in children and adults (Clin Inf Dis)
- Documents for J&J COVID-19 vaccine review (FDA)
- Convalescent plasma and clinical outcomes (JAMA)
- NIH halts convalescent plasma trial (NIH)
- Dexamethasone in hospitalized COVID-19 patients (NEJM)
- Tocilizumab in hospitalized COVID-19 patients (NEJM)
- Update on long COVID prevalence (UK ONS)
- Letters read on TWiV 727
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]